(Q38486711)

3 September 2017

Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer (English)

1 reference

3 September 2017

Lipponen P

1

1 reference

3 September 2017

1 January 1993

1 reference

European Journal of Cancer

3 September 2017

1 reference

3 September 2017

29A

1 reference

3 September 2017

749-753

1 reference

3 September 2017

5

1 reference

Breast cancer and a proto-oncogene

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Expression of c-erbB-2 protein product in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Molecular biology of urological tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

The epidermal growth factor receptor and the prognosis of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

A computer program for comparing K samples with right-censored data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Use of Immunohistochemically Demonstrated c-erb B-2 Oncoprotein Expression as a Prognostic Factor in Transitional Cell Carcinoma of the Urinary Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Expression of the c-erbB-2 protein in normal and transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

Relationship between DNA flow cytometric data, nuclear morphometric variables and volume-corrected mitotic index in transitional cell bladder tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980360-0

7 January 2021

10.1016/S0959-8049(05)80360-0

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

8097100